1. Home
  2. REBN vs VRAX Comparison

REBN vs VRAX Comparison

Compare REBN & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reborn Coffee Inc.

REBN

Reborn Coffee Inc.

N/A

Current Price

$0.78

Market Cap

11.5M

ML Signal

N/A

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$2.52

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
REBN
VRAX
Founded
2015
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
2.1M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
REBN
VRAX
Price
$0.78
$2.52
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
113.3K
481.9K
Earning Date
04-22-2026
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,094,628.00
N/A
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
36.54
N/A
52 Week Low
$0.67
$0.10
52 Week High
$2.95
$13.19

Technical Indicators

Market Signals
Indicator
REBN
VRAX
Relative Strength Index (RSI) 35.67 44.23
Support Level N/A $2.54
Resistance Level $2.02 $3.10
Average True Range (ATR) 0.14 0.17
MACD -0.03 -0.02
Stochastic Oscillator 21.07 14.29

Price Performance

Historical Comparison
REBN
VRAX

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is a company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in two reportable segments: Reborn Coffee, which includes both the wholesale and retail sales of coffee, water, and other beverages, and Reborn Logistics, which provides freight forwarding services.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: